MCI Onehealth Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MCI Onehealth Technologies generated cash of -$8,346,000, which is less than the previous year. Cash used in financing activities reached the amount of $3,783,000 last year. Net change in cash is therefore -$5,731,000.
Cash Flow
| 2017 | 3.50M | -596.42K | -2.40M |
|---|---|---|---|
| 2018 | 3.66M | -191.21K | -3.32M |
| 2019 | 3.21M | -121.88K | -2.89M |
| 2020 | 4.22M | -234K | -4.22M |
| 2021 | -7.09M | -8.64M | 21.99M |
| 2022 | -8.34M | -1.16M | 3.78M |
DRDR.TO Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 7.14M | 894K | 1.12M | 927.80K | 785.68K | 279.99K |
Operating activities | ||||||
Net income | -20.97M | -15.54M | -1.02M | -120.56K | -242.10K | -6.62K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 5.27M | 4.30M | 2.95M | 3.12M | 3.14M | 3.00M |
Stock-based compensation expense | 4.83M | 6.11M | 751K | 329.76K | 298.53K | 250.03K |
| Deferred income tax benefit | 4.83M | 6.11M | 751K | 329.76K | 298.53K | 250.03K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 695K | -1.50M | -1.21M | 164.88K | -455.54K | 267.31K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -8.34M | -7.09M | 4.22M | 3.21M | 3.66M | 3.50M |
Investing activities | ||||||
Purchases Of Investments | 0 | -810K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.16M | -2.36M | -234K | -121.88K | -192.01K | -381.57K |
Acquisitions Net | 0 | -5.46M | 0 | 0 | 0 | -276K |
Cash generated by investing activities | -1.16M | -8.64M | -234K | -121.88K | -191.21K | -596.42K |
Financing activities | ||||||
Common Stock Issued | 0 | 27.54M | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | -498K | -2.00M | 0 | 0 | 0 |
Repurchases of common stock | 0 | -870K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -3.79M | -2.70M | 0 | -2.98M | 0 |
Cash used in financing activities | 3.78M | 21.99M | -4.22M | -2.89M | -3.32M | -2.40M |
Net Change In Cash | -5.73M | 6.24M | -234K | 200.04K | 142.12K | 505.68K |
Cash at end of period | 1.41M | 7.14M | 894K | 1.12M | 927.80K | 785.68K |
| Data source | Data source | Data source | Data source | Data source | Data source |